Meridian Bioscience (VIVO) Reports In-Line Q4 EPS

November 10, 2016 7:48 AM EST
Get Alerts VIVO Hot Sheet
Trade VIVO Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Meridian Bioscience (NASDAQ: VIVO) reported Q4 EPS of $0.14, in-line with the analyst estimate of $0.14. Revenue for the quarter came in at $47 million versus the consensus estimate of $47.7 million.Meridian Bioscience reaffirmed FY2017 guidance.

For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment